Cardinal Health, Inc. $CAH Shares Purchased by MUFG Securities EMEA plc

MUFG Securities EMEA plc raised its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 4,501.6% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 210,340 shares of the company’s stock after purchasing an additional 205,769 shares during the quarter. MUFG Securities EMEA plc’s holdings in Cardinal Health were worth $43,225,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Redhawk Wealth Advisors Inc. raised its stake in Cardinal Health by 0.5% during the fourth quarter. Redhawk Wealth Advisors Inc. now owns 9,255 shares of the company’s stock valued at $1,902,000 after buying an additional 48 shares in the last quarter. HF Advisory Group LLC raised its stake in Cardinal Health by 0.9% during the fourth quarter. HF Advisory Group LLC now owns 5,227 shares of the company’s stock valued at $1,074,000 after buying an additional 49 shares in the last quarter. Hillsdale Investment Management Inc. raised its stake in Cardinal Health by 0.9% during the fourth quarter. Hillsdale Investment Management Inc. now owns 5,760 shares of the company’s stock valued at $1,184,000 after buying an additional 50 shares in the last quarter. Generali Asset Management SPA SGR raised its stake in Cardinal Health by 11.0% during the fourth quarter. Generali Asset Management SPA SGR now owns 513 shares of the company’s stock valued at $105,000 after buying an additional 51 shares in the last quarter. Finally, Stephens Inc. AR raised its stake in Cardinal Health by 0.9% during the fourth quarter. Stephens Inc. AR now owns 5,951 shares of the company’s stock valued at $1,223,000 after buying an additional 52 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Trading Down 1.6%

Shares of Cardinal Health stock opened at $196.57 on Friday. The business’s 50 day simple moving average is $203.52 and its 200-day simple moving average is $208.79. The stock has a market capitalization of $46.04 billion, a price-to-earnings ratio of 30.06, a PEG ratio of 1.17 and a beta of 0.53. Cardinal Health, Inc. has a twelve month low of $137.75 and a twelve month high of $233.60.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. The business had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business’s quarterly revenue was up 11.0% on a year-over-year basis. During the same period in the prior year, the firm earned $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Sell-side analysts predict that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be given a dividend of $0.5158 per share. This represents a $2.06 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Wednesday, July 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s payout ratio is currently 31.19%.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. Barclays upped their price objective on Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a research note on Tuesday, February 24th. Robert W. Baird set a $248.00 price objective on Cardinal Health in a research note on Friday, May 1st. William Blair assumed coverage on Cardinal Health in a research note on Tuesday, April 28th. They set an “outperform” rating on the stock. Argus upped their price objective on Cardinal Health from $232.00 to $248.00 and gave the company a “buy” rating in a research note on Wednesday, February 11th. Finally, TD Cowen upped their price objective on Cardinal Health from $251.00 to $255.00 and gave the company a “buy” rating in a research note on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $241.80.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.